Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stabilityAdam K Hedger, Wazo Myint, Jeong Min Lee, et al.
European Journal of Medicinal Chemistry|December 25, 2025
Fluorinated HIV-1 protease inhibitors containing chiral hydroxyethylbenzene and indanol as P2' ligands with potent activity against drug-resistant variantsJagroop Kaur, Ean Spielvogel, Desaboini Nageswara Rao, et al.
The Journal of Biological Chemistry|January 30, 2026
Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potentialRachel M Golonka, Lauren E Intravaia, Ala M Shaqra, et al.
ACS Infectious Diseases|June 30, 2023
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main ProteaseJulia M Flynn, Qiu Yu J Huang, Sarah N Zvornicanin, et al.
Nature Communications|June 21, 2022
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistanceAla M Shaqra, Sarah N Zvornicanin, Qiu Yu J Huang, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Cooperativity and Communication between the Active Sites of the Dimeric SARS-CoV-2 Main ProteaseSarah N Zvornicanin, Ala M Shaqra, Julia Flynn, et al.
Science Advances|January 16, 2026
Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main proteaseSarah N Zvornicanin, Ala M Shaqra, Julia Flynn, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 2